dilazep has been researched along with Obstructive Lung Diseases in 2 studies
Dilazep: Coronary vasodilator with some antiarrhythmic activity.
dilazep : A member of the class of diazepanes that is 1,4-diazepane substituted by 3-[(3,4,5-trimethoxybenzoyl)oxy]propyl groups at positions 1 and 4. It is a potent adenosine uptake inhibitor that exhibits antiplatelet, antianginal and vasodilator properties.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kishi, F | 1 |
| Kawakami, Y | 1 |
| Nishiura, Y | 1 |
2 other studies available for dilazep and Obstructive Lung Diseases
| Article | Year |
|---|---|
[Oxygen transport to the tissue].
Topics: Blood Gas Analysis; Dilazep; Humans; Hypoxia; Lung Diseases, Obstructive; Oxygen; Oxygen Consumption | 1983 |
[The effects of dilazep dihydrochloride and vitamin E on P50 in patients with chronic obstructive pulmonary disease].
Topics: Adult; Aged; Azepines; Dilazep; Female; Hemoglobins; Humans; Lung Diseases, Obstructive; Male; Middl | 1985 |